INTRODUCTION AND OBJECTIVES:
To assess and validate the ability of a previously designed simplified screening questionnaire (MADS) to predict hypogonadism in men.
METHODS: 1043 men who filled out the MADS questionnaire were analyzed, all of whom had complete data regarding questionnaire completion, age, and testosterone levels. A positive screen was defined as at least one question being answered in the affirmative. Mean testosterone levels were compared between participants for each question. Sensitivity and specificity analyses were performed for a positive screen in predicting hypogonadism (T<300ng/dL). Age and a positive MADS screen were explored as covariates in univariate and multivariate logistic regression models to predict the odds of having hypogonadism.
RESULTS: Overall, 452 (43.3%) men had T<300ng/dL. A total of 92 (8.9%) men had a positive screen on the MADS questionnaire. Forty (3.8%), 39 (3.7%), and 34 (3.3%) men answered yes to questions 1, 2, and 3, respectively. The differences in testosterone levels between patients who answered yes or no to each question are listed in Table 1 . Sensitivity and specificity of the questionnaire were 12.4% and 93.9%, respectively. The results of a multivariate logistic regression to predict low testosterone demonstrated that men with a positive MADS screen were significantly more likely to have hypogonadism (OR: 2.19, CI 1.41, 3.40, p[0. 00) compared to those that did not have a positive screen (Table 2) .
CONCLUSIONS: Logistic regression shows a significant ability to predict likelihood of hypogonadism in men with a positive MADS screen. The MADS questionnaire is a simplified and easy to administer screening tool that can be incorporated into the primary care setting.
Source of Funding: PCEC

MP40-07 THE PREDICTIVE EFFECT OF FREE TESTOSTERONE ON SEXUAL FUNCTION INCREASES WITH AGE
Maxwell Towe*, Linda M. Huynh, Farouk M. El-Khatib, Faysal A. Yafi, Thomas Ahlering, Orange, CA INTRODUCTION AND OBJECTIVES: While the impacts of age and testosterone on sexual function have been well-studied, the additive relationship of these three variables has seldom been mentioned. In the present study, we seek to assess the impact of testosterone and age on baseline sexual function in men with prostate cancer.
METHODS: We retrospectively reviewed 850 patients who presented for primary treatment of prostate cancer between December 2009 and June 2018. Preoperative sexual function was measured via the International Index of Erectile Function-5 (IIEF-5). Total and free testosterone (FT and TT) were collected and calculated preoperatively in 822 patients. To assess the impact of age, patients were stratified patients by decade of life and the most predictive cutoff was determined to be at 60 years of age. Univariate and multivariate analyses were conducted to assess impact of FT, TT, age, Body Mass Index (BMI), and pathological grade on sexual function. RESULTS: Overall, 822 patients were included, of which 35.4% (291/822) were <60 years. Mean FT was significantly higher in the <60 aged cohort (6.74AE4.24 ng/dL) vs. the >60 aged cohort (5.6AE2.52 ng/dL), (p<0.001). In multivariate analysis, FT was only an independent predictor of IIEF-5 scores for patients >60 years old (p[0.018), but not in patients younger than 60 (p[0.69). Similarly, BMI was not significantly correlated with sexual function in younger men (<60 years old) (p>0.05), but was an independent predictor in the older cohort (p<0.001). Age was an independent predictor of sexual function in both cohorts (p[0.001 for <60; p<0.001 for >60).
CONCLUSIONS: Our results show that lower FT levels do not impact IIEF-5 scores in patients <60 years old, but have a negative effect on IIEF-5 scores in patient >60 years old. In this group, that effect worsens with age. A FT level should be obtained in all patients over the age of 60 undergoing radical prostatectomy to assess postoperative sexual function recovery.
Source of Funding: None
MP40-08 DO PATIENTS WHO REPORT PREMATURE EJACULATION ACTUALLY EJACULATE QUICKER?
Jack Andrews*, Kevin Hebert, Mathew Ziegelmann, Ross Avant, David Yang, Tobias Kohler, Landon Trost, Rochester, MN INTRODUCTION AND OBJECTIVES: Premature ejaculation is a common complaint among men presenting with sexual dysfunction. However, limited data are available on the correlation between men who report they ejaculate too quickly and subjective intravaginal ejaculatory latency time (IELT). We sought to evaluate whether men who report premature ejaculation actually met criteria for premature ejaculation.
METHODS: We prospectively collected data on all men undergoing evaluation in a men's sexual health clinic between March 2014 and October 2016 at our institution. Statistical analysis was performed to evaluate outcomes in patients reporting premature ejaculation.
RESULTS: A total of 317 patients had data available on ejaculation including subjective IELT estimates. Of these men, 199 (63%) reported ejaculating too quickly, with a mean duration of symptoms of 8.2 years. Of patients who reported they ejaculated too quickly, 89% felt bothered by their symptoms, and 47% reported being able to delay ejaculation. Surprisingly, on univariate analysis, patients who reported ejaculating too quickly did not have significantly shorter IELT compared to those not reporting symptoms of rapid ejaculation (mean 8.39 vs 9.14 min, respectively, p[0.549). On subset analysis, men who consumed alcohol were significantly more likely to report rapid ejaculation (p[0.01) despite similar IELT estimates to men who did not consume alcohol. Similar findings were not observed with current or past smokers.
CONCLUSIONS: Patients who reported that they ejaculate too quickly had similar IELT times to those who did not report symptoms, with only 20% experiencing IELT <1 minute. These interesting findings highlight that perceived premature ejaculation is likely a poor surrogate for actual IELT times. (IIEF6) is the predominant method of assessing erectile function in urology. There are, however, three obvious and immediate problems with using the IIEF6 in the clinic to evaluate an individual patient: i) no account of the use of erectile aids such as intracavernosal injections; ii) a man not engaging in sexual intercourse cannot reach the accepted threshold for erectile function (24þ); iii) a man reporting no sexual activity is assigned a very low score (<6). We analyzed a large data set taken as part of routine care as well as a systematic comparison of the IIEF and EPIC sexual domain.
Source of
METHODS: Data were from close to 25,000 IIEF questionnaires completed by radical prostatectomy patients as part of routine clinical follow-up at our institution, and 1550 surveys from patients who completed both an IIEF6 and an EPIC questionnaire in a prospective study. We examined results before and after adding a question concerning use of erectile aids along with instruction that the IIEF6 was to reflect experience without use of the aid. We also added a question for men who reported no intercourse, asking for the reason why. EPIC sexual function scores were analyzed for men who reported no sexual activity on the IIEF6. RESULTS: Of 16,753 surveys including data on erectile aide usage, 15% reported use, predominately injections (89%). A simple modeling analysis demonstrated that before introduction of the erectile aid question, some men using erectile aids would report IIEF6 scores with use of the aid, whereas other would not. Of men reporting not attempting sexual intercourse, 46% (95% C.I. 43%, 49%) gave a reason other than erectile dysfunction including lack of a partner, sexual orientation, sexual preference and health problems of the female partner. In men who did have sexual intercourse, doubling the first 3 questions on the IIEF6 gave almost perfect scores compared to the full IIEF6 (mean difference -0.1, limits of agreement was -3.3, 3.1). In 251 men reporting no sexual activity, 13% reported erections sufficient for sexual activity and 5.6% reported scores of at least 65 on the EPIC sexual function domain.
CONCLUSIONS: Patient-reported outcome instruments for erectile function should include a question about erectile aids with patients asked to report experience without the use of aids. Lack of sexual activity and, more specifically, lack of sexual intercourse, cannot be taken as being indicative of erectile dysfunction.
Source of Funding:
This work was supported in part by the National Institutes of Health/National Cancer Institute (NIH/NCI) with a Cancer Center Support Grant to Memorial Sloan Kettering
